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Abstract
AIM
To analyze the association between oncohematological 
diseases and GSTT1 /GSTM1/CYP1A1  polymorphisms, 
dietary habits and smoking, in an argentine hospital-
based case-control study.
METHODS
This hospital-based case-control study involved 125 
patients with oncohematological diseases and 310 
control subjects. A questionnaire was used to obtain 
sociodemographic data and information about habits. 
Blood samples were collected, and DNA was extracted 
using salting out methods. Deletions in GSTT1 and GSTM1 
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(null genotypes) were addressed by PCR. CYP1A1 MspI 
polymorphism was detected by PCR-RFLP. Odds ratio (OR) 
and 95%CI were calculated to estimate the association 
between each variable studied and oncohematological 
disease.
RESULTS
Women showed lower risk of disease compared to men 
(OR 0.52, 95%CI: 0.34-0.82, P  = 0.003). Higher levels 
of education (> 12 years) were significantly associated 
with an increased risk, compared to complete primary 
school or less (OR 3.68, 95%CI: 1.82-7.40, P  < 0.001 
adjusted for age and sex). With respect to tobacco, 
none of the smoking categories showed association 
with oncohematological diseases. Regarding dietary 
habits, consumption of grilled/barbecued meat 3 or 
more times per month showed significant association 
with an increased risk of disease (OR 1.72, 95%CI: 
1.08-2.75, P  = 0.02). Daily consumption of coffee also 
was associated with an increased risk (OR 1.77, 95%CI: 
1.03-3.03, P  = 0.03). Results for GSTT1 , GSTM1 and 
CYP1A1  polymorphisms showed no significant association 
with oncohematological diseases. When analyzing the 
interaction between polymorphisms and tobacco smoking 
or dietary habits, no statistically significant associations 
that modify disease risk were found. 
CONCLUSION
We reported an increased risk of oncohematological 
diseases associated with meat and coffee intake. We 
did not find significant associations between genetic 
polymorphisms and blood cancer. 
Key words: Cancer; Oncohematological disease; Case-
control study; Lifestyle; Diet; Tobacco; Xenobiotic 
metabolizing genes; GSTT1; GSTM1; CYP1A1
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Core tip: Cancer is considered as a multi-factorial dis-
ease. Except certain genetic abnormalities, viruses, 
environmental exposures and chemotherapeutic agents, 
it is not well defined which are the risk factors for these 
diseases (leukemia, lymphoma, multiple myeloma, 
among others). Here, we analyzed lifestyle and genetic 
polymorphisms as risk factors for blood cancer. We 
reported an increased risk of disease associated with meat 
and coffee intake. No significant associations were found 
between metabolic gene polymorphisms and disease. 
Our study offers relevant insights into diverse aspects of 
oncohematological diseases etiology, particularly genes 
and environmental factors, in an Argentinean population.
Cerliani MB, Pavicic W, Gili JA, Klein G, Saba S, Richard S. 
Cigarette smoking, dietary habits and genetic polymorphisms 
in GSTT1, GSTM1 and CYP1A1 metabolic genes: A case-
control study in oncohematological diseases. World J Clin 
Oncol 2016; 7(5): 395-405  Available from: URL: http://www.
wjgnet.com/2218-4333/full/v7/i5/395.htm  DOI: http://dx.doi.
org/10.5306/wjco.v7.i5.395
INTRODUCTION
Xenobiotic metabolizing enzymes (XME), coded by a 
family of xenobiotic metabolizing genes (XMG), trans­
form endo and exogenous compounds in hydrophilic 
by­products, which are more easily excreted from 
the tissues[1]. It is well known since decades that 
genetic differences in the metabolism of drugs and 
environmental chemicals exist[2]. These differences are 
due to pharmacogenetic polymorphisms, which are allele 
variants that occur with a relatively high frequency in the 
population, and are generally associated with anomalies 
in gene expression or enzymatic function. Moreover, 
pharmacogenetic polymorphisms have been associated 
with an increased risk of some types of cancer, due 
to: (1) an impaired ability to inactivate endogenous or 
exogenous mutagenic molecules; or (2) the conversion 
of metabolites into highly reactive and toxic compounds. 
Both polymorphisms and the levels of exposure to their 
substrates, may impact on cancer susceptibility. 
The cytochrome P450 family of enzymes is responsible 
for catalyzing phase Ⅰ metabolism reactions. CYP1A1 is 
a member of the CYP family and plays an important role 
in the metabolism of estrogen and polycyclic aromatic 
hydrocarbons (PAHs), catalyzing the activation of pro­
carcinogenic PAHs[3]. Dysfunction of CYPs enzymes can 
cause damage to DNA, lipids and proteins, leading to 
carcinogenesis[4,5]. A commonly studied single nucleotide 
polymorphism (SNP) in CYP1A1 gene is the T3801C 
(also named MspI polymorphism, *2A or m1), a T to 
C mutation in the 3’ flanking region of the gene. The 
C variant becomes more highly inducible than the 
T variant[6], which may cause enhanced enzymatic 
activity, thus modifying susceptibility to adduct formation 
and cancer risk[7]. In fact, T3801C polymorphism was 
associated with leukemia and cervical, hepatocellular, lung, 
prostate, and head and neck cancer[8]. 
Glutathione S­transferases (GSTs) constitute a sup­
erfamily of phase II detoxification enzymes which play 
a key role in cellular protection against environmental 
carcinogens, drugs, toxins and by­products of oxidative 
stress. GSTs catalyze the conjugation of reduced gluta­
thione (GSH) to a wide variety of electrophilic compounds 
to facilitate their cellular excretion. In addition, as non­
enzymatic proteins, GSTs can modulate signaling 
pathways that control cell proliferation, cell differentiation, 
apoptosis, anti- and pro-inflammatory functions and DNA 
damage processing, among other processes[9]. Genetic 
polymorphisms in GST genes are common in the human 
population. GSTM1 and GSTT1 exhibit variations in copy 
number due to complete gene deletion, resulting in the 
loss of enzymatic activity. The absence of enzyme has 
been associated with lung, breast and gastrointestinal 
cancer, among others[10], and also with adverse side 
effects and toxicity in chemotherapies[11]. 
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Lifestyle and dietary habits are additional risk factors 
for cancer. Diet is known to modulate the immune 
system, and it may also influence cancer susceptibility 
through changes in the energy balance and in the levels 
of carcinogens and anticarcinogens[12]. Cigarette smoke 
contains more than 7000 chemicals and compounds, 
from which more than 70 are associated with cancer[13]. 
Benzene, present in tobacco smoke, is a strong carcinogen 
associated with leukemia and lymphoma development[14], 
and has long been recognized as hematotoxic[15]. 
It should not be forgotten that cancer susceptibility 
results from genetic and environmental factors, individually 
or in combination. According to this, it is expected that 
genetic, dietary and lifestyle factors interact with each 
others.
Several studies have inquired the epidemiologic risk 
factors associated with leukemia, lymphoma and/or 
myeloma. Except certain genetic abnormalities, viruses, 
environmental exposures and chemotherapeutic agents, 
little is known about risk factors that develop these 
onco­hematological diseases. 
Argentina is within the range of countries with 
medium to high incidence of cancer, according to the 
International Agency for Research on Cancer (IARC) 
data for 2012. They estimated an incidence of 14.2 new 
cases/year/100000 persons for Hodgkin lymphoma (HL), 
leukemia, non­Hodgkin lymphoma (NHL) and multiple 
myeloma (MM) all together[16]. During 2012, nearly 3830 
patients have died because of these diseases according 
to the Statistics and Health Information Office[17]. 
Between 2007 and 2011, oncohematological diseases 
account for the 6.5% of all cancer deaths[18]. 
The aim of this study was to analyze the association 
between oncohematological diseases and genetic 
polymorphisms in GSTT1, GSTM1 and CYP1A1, dietary 
habits and cigarette smoking, in an argentine hospital­
based case­control study.
MATERIALS AND METHODS
Subjects
A hospital­based case­control study was performed, 
involving 125 patients with oncohematological diseases 
and 310 control subjects. Participants were recruited 
between June 2013 and March 2015 at the Unit of 
Diagnosis, Treatment and Support for Hematological 
Diseases of the Acute Care General Hospital “Prof. Dr. 
Rodolfo Rossi” (La Plata, Buenos Aires, Argentina). The 
study was approved by the hospital’s Ethics Committee. 
The International Classification of Diseases for Oncology 
information was not available.
Cases were patients diagnosed with acute lympho­
blastic leukemia (ALL, n = 10), acute myeloblastic 
leukemia (AML, n = 18), chronic lymphoblastic leukemia 
(CLL, n = 10), chronic myeloblastic leukemia (CML, n 
= 20), MM (n = 29), HL (n = 18) and NHL (n = 20). 
Controls included patients frequently visiting the Unit 
for routine checks of disorders unrelated to cancer or 
preoperative blood analyses (i.e., for ophthalmic surgeries, 
pre­employment medical examinations, anemia, among 
others). All participants reside in Argentina. Cases and 
controls with previous history of cancer or pathologies 
closely related to oncohematological diseases were 
excluded from the study. 
Patients were invited to participate in the study and 
signed an informed consent. A questionnaire was used 
to obtain sociodemographic data and information about 
habits, such as cigarette smoking (never, former and 
current smoker), and consumption of grilled/barbecued 
meat (times per month), canned food (times per 
week), alcohol (times per week) and coffee (cups per 
day). No other food or beverage items were asked. 
The survey also included weight, height, medication, 
working conditions, family history of cancer, history of 
disease (only in cases), and functionality data (quality of 
sleep, fatigue, changes in appetite and mood, etc.). The 
overall case and control response rate was higher than 
90% for both groups.
All surveys were addressed by the same person. 
Blood samples were collected and kept in Vacutainer 
tubes with K2­EDTA (3.6 mg), and DNA was extracted 
from whole blood using salting out methods. 
GSTT1 and GSTM1 genotype assay
GSTT1 and GSTM1 gene deficiency resulted from the 
deletion of the loci (null alleles). The detection was 
performed by a multiplex PCR, using GSTT1 forward 
primer 5’­TTC CTT ACT ggT CCT CAC ATC TC­3’ and 
GSTT1 reverse primer 5’­TCA CCg gAT CAT ggC CAg 
CA­3’ (459 bp product), GSTM1 forward primer 5’­CTg 
CCC TAC TTg ATT gAT ggg­3’ and GSTM1 reverse primer 
5’­CTg gAT TgT AgC AgA TCA TgC­3’ (273 bp product), 
and a third pair of primers, forward 5’­TCC AgC AgT TTC 
ATg AgA TgC­3’ and reverse 5’­gAg gTC ATT TCA Tag CTg 
AgC­3’ for a 221 bp product of the gene CLOCK, as an 
internal control of the reaction (Figure 1). PCR conditions 
were as follows, in a final volume of 15 μL: 1 × buffer, 
50 ng DNA, 0.25 μmol/L each primer, 200 μmol/L dNTPs, 
2 mmol/L MgCl2, 0.45 U Taq Platinum Polymerase 
(Invitrogen, Life Technologies) and H2O up to 15 μL. PCR 
cycling consisted in an initial denaturation at 94 ℃ for 5 
min, followed by 35 cycles of 1 min at 94 ℃, 1 min at 
59 ℃ and 1 min at 72 ℃, with a final extension at 72 ℃ 
for 5 min. Verification of PCR products, and subsequent 
identification of genotype, were performed using 2% 
agarose gels stained with GelRed (Biotium Inc., CA, 
United States). The absence of PCR product defines the 
null allele. 
CYP1A1 genotype assay
MspI polymorphism was detected by PCR­RFLP. A 
product of 420 bp was amplified by PCR in a final 
volume of 15 μL, containing buffer 1 ×, 2 mmol/L 
MgCl2, 250 nmol/L each primer, 200 μmol/L dNTPs, 0.4 
U Taq DNA Polymerase Recombinant (Invitrogen), 30 
ng DNA and H2O up to 15 μL. Primers were: forward 
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5’­ACC CCA TTC TgT gTT ggg TT­3’ and reverse 5’­TAg 
AgA ggg CgT AAg TCA gCA­3’. Cycling conditions were 
as follows: An initial denaturation at 94 ℃ for 5 min, 
followed by 35 cycles of 30 s at 94 ℃, 30 s at 58 ℃ and 
40 s at 72 ℃, with a final extension at 72 ℃ for 5 min.
After checking amplification in 2% agarose gel 
stained with Gel Red, 7 μL of PCR product were digested 
with 5U of MspI enzyme (Thermo Scientific), buffer 
and H2O up to 15 μL. Incubation time was 5 h at 37 ℃. 
Verification of digested products was carried out in 2% 
agarose gels stained with Gel Red. The C variant has 
the restriction site, generating 237 and 183 bp products 
(Figure 2). 
Statistical analysis
Odds ratio (OR) and 95%CI were calculated to estimate 
the association between each variable studied and 
oncohematological disease. χ 2 test was applied to obtain 
the statistical significance of the association. Analyses 
were performed with the softwares STATA 11.1[19] and 
Epidat 4.0[20]. Genotype and allele frequencies were 
calculated and tested for Hardy­Weinberg Equilibrium 
using the software GenAlEx 6.5[21]. The sample size of 
this survey achieved 80% power to detect an OR = 2. 
P­values ≤ 0.05 were considered statistically significant. 
The statistical review of the study was performed by a 
biomedical statistician (Gili JA, one of the authors).
RESULTS
Study population
In this association study, a total of 125 cases were 
compared to 310 controls, all of them patients from the 
Acute Care General Hospital “Prof. Dr. Rodolfo Rossi”. 
Demographic characteristics are listed in Table 1, and 
were already published by our group in Cerliani et 
al[22]. Missing data for each variable were not included 
in the analysis, nor are detailed in the tables. The 
maximum number of missing data in a variable was 18, 
representing 4.14% of the samples. Of all variables in 
the questionnaire, only height and weight were excluded 
due to > 10% missing data. There was no significant 
difference in the mean age of cases and controls. 
Women showed lower risk of disease compared to men 
(OR 0.52, 95%CI: 0.34­0.82, P = 0.003). Higher levels 
of education (> 12 years) were significantly associated 
with an increased risk, compared to complete primary 
school or less (OR 3.68, 95%CI: 1.82­7.40, P < 0.001 
adjusted for age and sex). Marital status did not show 
association with the disease.
Tobacco, dietary habits and XMG polymorphisms
With respect to tobacco, none of the smoking cate­
gories showed association with oncohematological 
diseases. Regarding dietary habits, consumption of 
grilled/barbecued meat 3 or more times per month 
showed significant association with an increased risk 
of disease (OR 1.72, 95%CI: 1.08­2.75, P = 0.02). 
Daily consumption of coffee also was associated with 
an increased risk (OR 1.77, 95%CI: 1.03­3.03, P 
= 0.03). Since control patients with gastrointestinal 
problems could create a spurious OR (given that they 
may be abstaining from coffee), patients from the 
Gastroenterology Unit of the hospital were removed from 
the analysis, as well as control patients under treatment 
with gastric protectors or medication prescribed for 
other gastrointestinal issues. Therefore 19 controls 
were excluded from the analysis; nevertheless, coffee 
consumption still remains statistically correlated with 
disease, showing the same OR range (OR 1.01­3.02). No 
association was observed with consumption of canned 
food or alcohol. When assessing the risk associated 
with consumption of coffee and grilled/barbecued 
meat, within each of the pathologies, results showed no 
differences between groups for coffee consumption, but 
CML and MM cases exhibited a significant association 
with consumption of grilled/barbecued meat 3 or more 
times per month, adjusted for age, sex and educational 
Figure 1  Gel electrophoresis showing PCR products of GSTT1 (459 bp), 
GSTM1 (273 bp) and CLOCK (221 bp). Numbered lanes represents: 1: 100 bp 
molecular weight marker; 3, 4, 8: T+/M+; DNA from samples with positive GSTT1 
and GSTM1 alleles, plus control CLOCK gene band; 7: T-/M-; Double null 
genotype of GSTM1 and GSTT1 (in the presence of CLOCK PCR product); 5, 6, 
9: T+/M-; GSTT1 positive/GSTM1 null; 2: T-/M+; GSTT1 null/GSTM1 positive.
Figure 2  Gel electrophoresis showing PCR-RFLP product of CYP1A1 
gene digested with MspI restriction enzyme. CYP1A1 gene T3801C variant 
gives the following digestion band patterns: TT, 420 bp; TC, 420 bp and 237 
bp + 183 bp; and CC, 237 bp + 183 bp. Numbered lanes represents: 1: 100 bp 
molecular weight marker; 2, 5: CC homozygous type; 3, 4, 7: TC heterozygous 
type; 6, 8, 9: TT homozygous type.
1         2      3        4       5        6       7        8        9
1         2       3        4        5        6        7       8        9
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level (data not shown). With regard to GSTT1, GSTM1 
and CYP1A1 polymorphisms, results showed no sig­
nificant association with oncohematological diseases. 
CYP1A1 MspI polymorphism was not in Hardy­Weinberg 
equilibrium. Allele and genotype frequencies are de­
tailed in Table 2. Results from the association analysis 
between tobacco, dietary habits, XMG polymorphisms 
and oncohematological diseases are described in 
Table 3. When analyzing the interaction between XMG 
polymorphisms and tobacco smoking or dietary habits, 
no statistically significant associations that modify disease 
risk were found (data not shown).
DISCUSSION
Carcinogenesis is considered as a multi­step and multi­
factorial process that implied different genetic alterations 
and several biological pathways. Thus, it is expected 
that cancer risk factors interact with each others. 
Genetic polymorphisms may play different roles in cancer 
susceptibility according to the genetic background, 
environmental exposures and lifestyles[8]. Despite this, 
we did not find evidence of interaction between genetic 
and lifestyle factors, probably because the sample size is 
not big enough for this type of analysis.
Regarding tobacco use and dietary habits, we 
reported an increased risk of oncohematological diseases 
associated with grilled/barbecued meat intake 3 or more 
times per month, and with daily consumption of coffee, 
after adjustment for age, sex and educational level. 
Moreover, for both factors that showed an increased 
risk when analyzing all malignancies combined, we 
have also assessed the risk associated with each of the 
major groups within the case category. While for coffee 
consumption results showed no differences between 
groups, grilled/barbecued meat intake (3 times or more 
per month) has shown a significant correlation with CML 
and MM cases. However, it has to be considered that 
the sample size becomes small when divided by each 
pathology. Therefore, the real effect of each risk factor 
for a specific type of leukemia, lymphoma or myeloma 
might be determined in future studies by analyzing a 
larger set of samples.
Although cigarette smoke has been associated 
with mutagenic/carcinogenic effects, inflammation 
and immune suppression in animals and humans[23,24], 
previous studies on cigarette smoking and its association 
with blood cancers have generated inconsistent findings. 
Regarding NHL, studies reported little or no association 
Table 1  Demographic characteristics of the population under study n  (%)
Cases n  = 125 Controls n  = 310 OR (95%CI) P
Age mean (SD)   48.5 (16.6)    51 (18.5) -   0.507
Sex
  Male      74 (59.2)  134 (43.2) Ref.   0.003
  Female      51 (40.8)  176 (56.8)   0.52 (0.34-0.82)
Education
  ≤ 7 yr (complete primary school or less)      174 (56.31) 55 (44) Ref. 
  12 yr (complete secondary school)      115 (37.22)    48 (38.4)     1.2 (0.73-1.95) < 0.0011
  > 12 yr (complete college)      20 (6.47)    22 (17.6) 3.68 (1.82-7.4)
Marital status
  Single       79 (25.48)    27 (21.6) Ref. 
  In couple/married      162 (52.26)    86 (68.8)     1.7 (0.99-2.95)   0.051
  Divorced/separated      27 (8.71) 5 (4) 0.64 (0.21-1.9)   0.421
  Widowed        42 (13.55)    7 (5.6)    0.75 (0.27-2.13)   0.591
Type of malignancy
  ALL 10 (8)
  AML      18 (14.4)
  CLL 10 (8)
  CML   20 (16)
  MM      29 (23.2)
  HL      18 (14.4)
  NHL   20 (16)
1Adjusted for age and sex. P < 0.05 considered statistically significant. ALL: Acute lymphoblastic leukemia; AML: Acute myeloblastic leukemia; CLL: 
Chronic lymphoblastic leukemia; CML: Chronic myeloblastic leukemia; MM: Multiple mieloma; HL: Hodgkin lymphoma; NHL: Non-Hodgkin lymphoma; 
Ref: Reference category; SD: Standard deviation. 
Table 2  Allele and genotype frequencies for CYP1A1 *2A 
polymorphism, and GSTT1/GSTM1 null polymorphisms
Cases n  = 125 Controls n  = 310
Allele frequencies
  CYP1A1 
     T 0.7 0.65
     C 0.3 0.35
Genotype frequencies (n)
  GSTT1*null 0.18 (22) 0.18 (55)
  GSTM1*null   0.5 (61)   0.47 (140)
  CYP1A1
     TT 0.53 (64)   0.47 (140)
     TC 0.34 (42)   0.37 (113)
     CC 0.13 (16) 0.16 (47)
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with use of cigarettes/tobacco, or patterns related with 
duration or intensity of exposure (detailed in[25­27]). In a 
case­control study from Sweden, the effects of smoking 
on the risk of AML were weak and no significant[28]. 
However, a cohort study from the same country showed 
a 50% increased risk of AML for current smokers[29]; this 
study also indicated no association between current and 
former smokers with CML, ALL, CLL or MM. An Indian 
case­control study reported an increase of 2.1 fold in the 
risk of leukemia in the cigarette smokers, compared to 
non­smokers[30]. A US cohort study that evaluated risk 
factors for AML, showed hazard ratios of 1.79, 2.42 and 
2.29 for former smokers of > 1 pack/d, current smokers 
of ≤ 1 pack/d, and current smokers of > 1 pack/d, 
respectively[31]. A meta­analysis done by Fircanis et al[32] 
including over 7500 cases of AML, found an increased risk 
of disease associated with smoking, regardless of sex, 
geographical region, study design and quality of studies. 
They also reported a higher risk with higher intensity and 
longer duration of smoking. 
It is possible that the exposure to agents present 
in the smoke varies given the different usage patterns, 
exposure pathways and manufacturing processes. 
A recent study done by Rubinstein et al[33] showed 
that 29.7% of the general population of Argentina, 
Chile and Uruguay (n = 7524) smoke cigarettes. The 
CARMELA study (Cardiovascular Risk Factor Multiple 
Evaluation in Latin America), performed between 2003 
and 2005, reported that Buenos Aires (Argentina, n = 
1482) and Santiago (Chile, n = 1655) have the highest 
smoking prevalence among the seven Latin American 
cities studied, with no gender differences (38.6% and 
45.4% respectively)[34]. Our study reports that 20.9% 
of the controls and 22% of the cases are current 
smokers, with higher percentages for former smokers 
(32.7% for controls and 38.2% for cases). These 
results are probably due to that this study is based on 
hospital population, which strongly encourages quitting. 
Considering the high proportion of people exposed to 
tobacco in these countries, it would be interesting to 
continue assessing its impact on the development of 
blood cancer, given the limited information available. 
Diet, probably among the most modifiable environ-
mental factors, contributes to the development of 
30%­35% of cancers[35]. Association studies in the field 
may be inconsistent due to differences in the frequency 
of food intake, varieties of available food, and different 
methods of preparation among populations. 
According to a recent publication of the IARC Mono­
graph Working Group, consumption of processed meat 
was classified as “carcinogenic to humans” (group 1), 
and consumption of red meat as “probably carcinogenic 
to humans” (group 2A)[36]. Meat processing can result 
in formation of N­nitroso compounds and PAH, while 
cooking it can produce heterocyclic aromatic amines 
and PAH. High­temperature cooking, such as grilling 
and barbecuing, produces the highest amounts of these 
carcinogens. Barbecued red meat is a frequent dish 
Table 3  Association between tobacco, dietary habits, xenobiotic metabolizing genes polymorphisms, and oncohematological diseases 
n  (%)
Cases n  = 125 Controls n  =310 OR (95%CI) P
Tobacco smoking status
  Never      49 (39.8) 142 (46.4) Ref.
  Former      47 (38.2) 100 (32.7) 1.36 (0.84-2.19) 0.202
  Current   27 (22)    64 (20.9) 1.22 (0.70-2.13) 0.478
Consumption of canned food
  0-2 times/wk    121 (96.8) 292 (94.8) Ref. 0.370
  3 or more times/wk      4 (3.2) 16 (5.2) 0.60 (0.14-1.92)
Consumption of grilled/barbecued meat
  0-2 times/mo      69 (55.2) 217 (70.7) Ref. 0.0211
  3 or more times/mo      56 (44.8)   90 (29.3) 1.72 (1.08-2.75)
Alcohol drinking
  0-3 times/wk 110 (88) 268 (86.5) Ref. 0.665
  4 or more times/wk   15 (12)   42 (13.5) 0.87 (0.43-1.68)
Consumption of coffee
  < 1 cup/d   90 (72) 259 (83.5) Ref. 0.0371
  1 or more cups/d   35 (28)   51 (16.5) 1.77 (1.03-3.03)
GSTT1
  Presence 100 (82) 245 (81.7) Ref. 0.942
  Null   22 (18)   55 (18.3) 0.98 (0.54-1.74)
GSTM1
  Presence   61 (50) 160 (53.3) Ref. 0.534
  Null   61 (50) 140 (46.7) 1.14 (0.73-1.78)
CYP1A1 
  TT      64 (52.5) 140 (46.7) Ref. 0.280
  TC + CC      58 (47.5) 160 (53.3) 0.79 (0.51-1.24)
1Adjusted for age, sex, and educational level. P < 0.05 considered statistically significant. Ref.: Reference category. 
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among the Argentinean population, where there is a high 
consumption of animal protein and fats obtained mainly 
from red meat[37,38]. Several epidemiologic studies from 
Córdoba, an Argentinean province, report significant 
associations between consumption of red meat, or dietary 
patterns that contains it, and breast, colorectal, prostate, 
and urinary tract cancers[37­42]. According to Navarro et 
al[38], all meats were associated with an increased risk for 
colorectal cancer when barbecued, a similar result to that 
observed in our study. In two other surveys, the Southern 
Cone dietary pattern (red meat, starchy vegetables and 
wine consumptions) was associated with higher risk of 
urinary tract tumors[39] and colorectal cancer[37]. In a case­
control study from Uruguay, red meat, lamb, and boiled 
meat were associated with the risk of squamous cell 
carcinoma of the esophagus[43]. 
In relation to oncohematological diseases, there are 
no studies in Argentina concerning diet and lifestyle as risk 
factors. Several studies from other countries evaluated 
this possible association, with inconsistent results. Most of 
them reported no association between meat consumption 
and increased risk of NHL or CML[44­46]. A case­control 
study from US done by Li et al[47] reported a positive 
association between an increased risk of AML and beef 
intake among women. Our results are the first to report 
a significant association between oncohematological 
diseases and consumption of barbecued/grilled meat 
in our population. However, some bias could exist since 
portion size was not assessed, and the questionnaire does 
not differentiate between red and white meat. Despite 
this, our results are relevant given the fact of a high and 
frequent consumption of these foods in Argentina. 
It has been suggested that light to moderate alcohol 
consumption has beneficial effects due to advantageous 
host cellular and humoral immune responses[48]. On 
the other hand, ethanol was classified as carcinogenic 
to humans by the IARC. Regarding hematologic 
malignancies, a pooled analysis from the International 
Lymphoma Epidemiology Consortium reported that ever or 
current drinking were associated with a lower risk of NHL, 
compared with non­drinkers[49]. However, they did not find 
a dose­response relation or a stronger trend with longer 
duration. A meta­analysis performed with 18 studies, 
including 5694 cases with MM and 7142 with leukemia, 
did not find any association between alcohol drinking and 
MM or leukemia risks[50,51]. As with beef consumption, Li 
et al[47] reported a positive association between beer and 
wine intake and AML, only among women. An Italian 
case­control study showed no clear association between 
leukemia or NHL and alcohol consumption[27]. In line with 
some of these reports, we found no association between 
alcohol consumption and oncohematological diseases in 
the Argentinean population under study. 
Regarding coffee consumption, there is no consistent 
evidence suggesting protective or deleterious effects. On 
the one hand, coffee may decrease the risk of cancer 
through antioxidant, antihormonal, and anti-inflammatory 
mechanisms[52]. On the other hand, caffeine and Topo Ⅱ 
inhibitors may elevate cancer risk. A United States cohort 
study reported no association between coffee intake and 
risk of all cancers combined, but they observed a decrease 
in the risk of endometrial cancer for women drinking 1 
or more cups per day[53]. Although some studies on solid 
tumors have reported a protective effect (i.e., on liver, 
colorectal, breast and endometrial cancer[54­57]), studies 
on hematopoietic malignancies in adults are rare. In 
our study, daily consumption of coffee was associated 
with an increased risk of disease. An Indian case­control 
study showed a 40% reduction in the risk of leukemia 
for coffee drinkers[30], while an Italian one reported an 
increase in the risk of NHL[58]. Other studies found no 
significant associations between coffee consumption and 
hematologic cancer[44,59,60]. In 1991, the IARC Working 
Group classified coffee as possibly carcinogenic to humans 
(group 2B). Given the large number of studies published 
on the subject since that IARC publication, the IARC 
Advisory Group recommends a review of the evidence, 
giving to this exposure high priority for its inclusion in the 
monographs to be published between 2015 and 2019[61]. 
Genetic variations in XMG may be important factors 
in the etiology of onco­hematological diseases. Although 
they have low penetrance, they are highly prevalent 
in most populations, giving the chance to identify 
potential carcinogens and populations at higher risk 
of cancer[62]. These polymorphisms also interact with 
other polymorphisms and/or particular environmental 
factors, which vary between and within ethnic groups[8]. 
The increased activity/inducibility of CYP1A1*2A may 
contribute to the accumulation of genetic changes due 
to an increased production of mutagenic agents. In a 
similar way, the decreased activity of GSTs due to gene 
deletions may lead to a more intense cellular oxidative 
stress, increasing the level of DNA damage. 
Regarding CYP1A1 MspI polymorphism, allele fre­
quencies vary between ethnic groups, being 0.058, 0.149 
and 0.218 for the C allele (*2A) in Caucasians, Asians 
and Africans, respectively[63]. Roco et al[64] reported a *2A 
allele frequency of 0.37 for a Chilean population. In this 
study, *2A allele frequencies were 0.34 for controls and 
0.30 for cases, similar to that described for the Chilean 
population and away from that reported for Caucasians. 
Our genotypic data about this polymorphism deviate from 
Hardy­Weinberg equilibrium; this may be because the 
sample does not represent the entire population variability, 
or due to genotyping errors that create a bias towards 
increased homozygosity.
Our association analysis between MspI polymorphism 
and blood cancer showed an OR = 0.79 (95%CI: 
0.51­1.24), with no statistical significance. Association 
studies between CYP1A1 MspI polymorphism and cancer 
have been inconsistent. A meta­analysis from 268 
studies performed by He et al[8] showed that the variant 
*2A was associated with an increased risk of leukemia, 
cervical, hepatocellular, head and neck, lung and prostate 
cancer, but not with other cancer types. Another meta­
analysis done by Han et al[65] reported a higher risk of 
leukemia associated with this variant, which remains 
significant for Caucasians when stratified by ethnicity. 
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They also reported an increased risk for ALL and AML, 
especially in childhood ALL in Caucasians. Among 
Asians, Lu et al[66] showed that the presence of the MspI 
polymorphism increased the risk of AML. On the other 
hand, a meta­analysis performed by Zhuo et al[67] did not 
find significant associations between CYP1A1 variant and 
AML risk.
Many studies have analyzed the possible association 
between hematological cancer and the deletions of 
GSTT1 and GSTM1, with disparate results. In this study, 
frequencies for null genotypes were 0.18 in cases and 
controls for GSTT1, and 0.5 and 0.47 for GSTM1, in 
cases and controls respectively. Reported frequencies for 
GSTT1*null in controls were 0.13­0.26 for Caucasians[63], 
0.10­0.12 for Chilean and Argentinean populations[64,68­70], 
and 0.09­0.24 for Native American Argentineans[71]. 
GSTM1*null has higher frequencies, with values of 
0.42­0.60 for Caucasians[63], 0.36­0.46 for Chilean and 
Argentinean populations[64,68­70], and 0.29­0.49 for Native 
American Argentineans[71]. Our study showed an OR = 
0.98 (95%CI: 0.54­1.74) for the GSTT1 deletion, and 
an OR = 1.14 (95%CI: 0.73­1.78) for GSTM1 deletion. 
He et al[62] carried out a meta­analysis, showing that 
GSTM1*null genotype significantly increased the risk 
of AML in East Asians, while GSTT1*null increased it in 
Caucasians. Double­null genotypes were associated with 
AML in both ethnic groups. Several case­control studies 
reported significant associations between GSTT1*null 
genotype and AML, CML, CLL and acute leukemia[72­78]. 
Conversely, other studies did not find such associations 
with all leukemia, acute leukemia, CML, AML or MM[79­82]. 
A similar scenario occurs with GSTM1*null genotype: 
many studies showed a significant increased risk of NHL, 
CLL, AML, MM, CML, and acute leukemia associated 
with the null genotype[72,73,76,78,83,84], while other ones 
reported no differences in cancer risk between controls 
and CML, AML, MM, acute leukemia and all leukemia 
cases[74,75,77,79­82]. In general, studies reported moderate 
OR, with values from 1 to 3; however, values up to 7 
were reached in some assays, with OR values even 
greater when analyzing double null genotypes. It should 
be noted that these case­control studies are from 
different countries with different ethnic backgrounds, and 
with a variable number of participants. 
Our study has strengths that are worth mentioning. 
Face­to­face interviews were performed by the same 
person, with all cases and controls, thus addressing 
reliable data about personal information, habits and 
lifestyle. Furthermore, although sample size is small, it 
has the power to detect an OR = 2, a value close to that 
reported in similar case­control studies. Even though 
cases and controls were not age­ and gender­matched, 
statistical adjustment were used to minimize potential 
biases. It should be recall that hospital­based studies 
may have some bias, due to controls that might have 
benign diseases which are prone to turn malignant. 
This study design could reduce the generalization of 
the results to the general population. Additionally, 
hematological malignancies are heterogeneous illnesses, 
with potentially different causes. A larger number of 
samples will allow us to conduct studies of risk factors 
for each pathology independently. 
There is a lack of studies for oncohematological 
diseases etiology in an argentinean population, particularly 
for genes and environmental factors. Taking that into 
account, our goal through the study was to address 
and offers relevant insight into diverse aspects for these 
pathologies in our population.
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Background
Risk factors for oncohematological diseases are not completely defined. As in 
other cancer pathologies, blood cancer susceptibility is related to both lifestyle 
and genetic factors. In regards to the Argentinean population, these pathologies 
are barely studied, even in relation to highly frequent risk factors for this 
population.
Research frontiers
In the latest years, although specific diet patterns for Argentina have been 
evaluated as risk factors related to cancer development by many studies, 
hematological cancer was not included. Moreover, studies about tobacco, 
alcohol and coffee as risk factors for oncohematological diseases are still not 
conclusive; furthermore, the results can vary between different populations and 
study designs. On the other side, genetic variants in coding genes for enzymes 
associated to carcinogenic compounds metabolization are known genetics 
risk factors linked to cancer. Allelic frequencies for these enzymatic variants 
are different between populations; therefore, it becomes difficult to extrapolate 
an estimated risk from one population to another. For Argentina, genetic 
frequencies for metabolizing enzymes are already known; however, available 
data are limited to just a few cities and, mostly, for healthy population.
Innovations and breakthroughs
In that regards, in this work the authors reported an association between 
oncohematological diseases with coffee and meat intake. With respect to the 
latter risk factor, the result becomes extremely relevant given the fact of high 
meat consumption in Argentina. The results are the first one showing a possible 
association in the authors’ population. Moreover, Argentina has a medium-
high cancer incidence; every research implying an evaluation of different risk 
factors frequently found in the population, could help in contributing with new 
information, in order to dilucidate which specific factors are really involved in 
the actual incidence of blood related cancer diseases.
Applications
The result could be joined with the whole set of studies looking to evaluate 
the impact of genetics and lifestyle factors in cancer development. The results 
reported for coffee and barbecued/grilled meat intake, could be taken into 
account to go deeply in future studies by evaluating specific kinds of meat, 
portion size, other cooking methods, etc. This could allow researchers to 
classify, more specifically, which particular characteristics related to nutrition 
patterns are associated with cancer development in a population. Additionally, 
each oncohematological pathology could be also analyzed individually from the 
main group, due to the fact that each specific genetic or lifestyle factor could be 
involved in different pathways and/or specific disease stages, independently.
Terminology
Odds ratio (OR), in statistics, the OR is a way to quantify how strongly the 
presence or absence of property A is associated with the presence or absence 
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of property B in a given population. Oncohematological diseases or hematology-
oncology, the diagnosis, treatment and prevention of cancer developed in blood 
cells, and the research associated to them. Hematology-oncology includes 
diseases such as leukemias and lymphomas, as well as other blood disorders 
(i.e., iron deficiency anemia, hemophilia, sickle cell disease, and thalassemias).
Peer-review
The study indicates an increased risk of oncohematological diseases 
associated with meat and coffee intake. Overall the manuscript was written in a 
clear and concise manner.
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